NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,875,136 | +32.2% | 45,184 | +91.5% | 0.01% | +20.0% |
| Q1 2023 | $1,418,642 | -61.7% | 23,589 | -52.2% | 0.01% | +66.7% |
| Q4 2021 | $3,708,000 | +92.7% | 49,390 | +198.2% | 0.00% | +50.0% |
| Q3 2021 | $1,924,000 | +106.4% | 16,563 | +5.4% | 0.00% | -50.0% |
| Q2 2020 | $932,000 | +291.6% | 15,714 | +456.8% | 0.00% | +100.0% |
| Q4 2019 | $238,000 | +230.6% | 2,822 | +194.6% | 0.00% | +100.0% |
| Q3 2019 | $72,000 | -90.9% | 958 | -93.6% | 0.00% | -83.3% |
| Q3 2018 | $787,000 | +175.2% | 15,019 | +64.6% | 0.01% | +200.0% |
| Q2 2018 | $286,000 | +1942.9% | 9,124 | +1369.2% | 0.00% | – |
| Q1 2018 | $14,000 | -92.4% | 621 | -93.2% | 0.00% | -100.0% |
| Q4 2017 | $185,000 | +444.1% | 9,146 | +506.5% | 0.00% | – |
| Q4 2015 | $34,000 | – | 1,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |